clinic
impact
viral
factor
type
viral
load
respiratori
syncyti
viru
rsv
infect
still
controversi
especi
regard
newli
describ
genotyp
studi
infant
rsv
bronchiol
recruit
describ
associ
viral
factor
sever
infect
rsv
antigen
type
genotyp
viral
load
determin
hospit
patient
hospit
roberto
del
santiago
chile
case
character
demograph
clinic
inform
includ
day
lower
respiratori
symptom
sever
total
patient
includ
moder
sever
case
rsva
domin
rsvb
predomin
phylogenet
analys
reveal
circul
bueno
air
ba
ontario
genotyp
associ
observ
sever
infect
rsv
group
p
genotyp
p
clinic
categor
durat
ill
higher
rsv
genom
load
detect
infant
evalu
earlier
diseas
p
also
infant
evalu
later
cours
sever
infect
p
although
type
genotyp
associ
sever
children
higher
rsv
genom
load
delay
viral
clearanc
sever
patient
defin
group
might
benefit
new
antivir
therapi
respiratori
syncyti
viru
rsv
common
caus
lower
respiratori
tract
infect
lrti
children
import
agent
elderli
immunocompromis
patient
gener
global
public
health
problem
chile
rsv
caus
import
outbreak
winter
account
high
number
outpati
visit
hospit
actual
treatment
mainli
support
although
immunoprophylact
therapi
palivizumab
synagi
medimmun
inc
gaithersburg
md
usa
approv
infant
high
risk
sever
infect
hospit
rsv
infect
infant
meet
criteria
immunoprophylaxi
moreov
highrisk
condit
present
approxim
rsv
hospit
infant
make
difficult
predict
develop
sever
diseas
pathogenesi
rsv
remain
topic
intens
basic
clinic
research
emphasi
host
genet
immunolog
viral
environment
factor
relat
sever
infect
rsv
classifi
group
b
base
antigen
differ
g
f
n
protein
genet
analysi
nucleotid
sequenc
second
hypervari
region
g
gene
allow
classif
genotyp
within
antigen
group
rsva
b
mani
studi
report
molecular
epidemiolog
genet
variabl
rsv
worldwid
reveal
emerg
spread
new
genotyp
duplic
nucleotid
g
hypervari
region
rsva
rsv
ontario
rsvb
rsv
bueno
air
although
none
variant
genotyp
consist
associ
greater
virul
pathogen
recent
report
describ
clinic
aspect
contemporari
genotyp
shown
higher
frequenc
lrti
hospit
rate
anoth
viral
factor
explor
determin
respiratori
diseas
sever
viral
load
respiratori
tract
studi
detect
correl
rsv
load
diseas
sever
hospit
infant
other
report
higher
viral
load
predict
longer
durat
hospit
latest
recent
confirm
multicent
prospect
cohort
includ
children
rsv
bronchiol
thu
earli
intervent
antivir
therapi
initi
time
highest
viral
replic
approxim
third
fifth
day
symptom
could
improv
prognosi
diseas
directli
reduc
viral
cytopath
effect
inflammatori
respons
aim
studi
describ
molecular
viral
factor
rsv
group
genotyp
viral
genom
load
chilean
infant
two
consecut
rsv
epidem
explor
relationship
sever
diseas
total
hospit
infant
rsv
lrti
recruit
case
outbreak
outbreak
santiago
exclud
four
immunofluoresc
assay
ifa
posit
rsv
case
could
confirm
qpcr
thu
data
infant
avail
analysi
median
age
day
male
base
clinic
score
infant
determin
moder
sever
diseas
similar
frequenc
epidem
outbreak
p
tabl
demograph
medic
histori
clinic
characterist
sever
infect
present
signific
differ
found
age
gender
medic
histori
length
stay
requir
supplement
oxygen
fio
mechan
ventil
significantli
higher
sever
group
rsv
pathogen
detect
case
coinfect
observ
patient
coinfect
pattern
case
rsvhuman
rhinoviru
hrv
case
rsvcoronaviru
cov
case
rsvparainfluenza
viru
type
case
rsvhrvbocaviru
signific
associ
found
demograph
clinic
featur
coinfect
tabl
nevertheless
observ
coinfect
frequent
patient
famili
histori
asthma
atopi
p
antigen
group
rsva
n
rsvb
n
detect
show
differ
circul
frequenc
compar
two
epidem
season
p
shown
figur
outbreak
rsva
strain
domin
frequenc
n
contrast
major
group
rsvb
found
n
patient
differ
sever
infect
detect
antigen
group
figur
p
moreov
signific
correl
found
rsv
group
sever
spearman
rho
p
genotyp
determin
perform
sampl
sequenc
virus
rsva
cluster
refer
virus
genotyp
n
n
supplementari
figur
rsvb
virus
cluster
refer
virus
genotyp
ba
n
shown
supplementari
figur
found
differ
diseas
sever
ba
genotyp
figur
signific
differ
viral
genom
load
detect
rsv
infect
infant
rsv
sole
infect
coinfect
vs
p
interestingli
signific
differ
respiratori
viral
genom
load
detect
rsv
antigen
group
figur
p
rsvb
infect
infant
higher
median
viral
genom
load
rsva
infect
infant
although
higher
viral
genom
load
detect
nasal
secret
sever
case
vs
differ
statist
signific
figur
p
viral
genom
load
also
analyz
durat
lrti
time
sampl
illustr
figur
significantli
higher
viral
genom
load
found
infant
day
less
lower
respiratori
tract
symptom
compar
day
p
thu
higher
viral
load
detect
rsv
infect
infant
earlier
lrti
present
vs
final
analyz
stage
day
lrti
present
sever
infect
figur
found
viral
genom
load
day
less
lrti
compar
moder
sever
lrti
vs
p
howev
later
lrti
stage
day
infant
sever
rsv
lrti
significantli
higher
viral
genom
load
vs
p
signific
differ
viral
genom
load
detect
rsv
infect
infant
rsv
sole
infect
coinfect
vs
p
interestingli
signific
differ
respiratori
viral
genom
load
detect
rsv
antigen
group
figur
p
rsvb
infect
infant
higher
median
viral
genom
load
rsva
infect
infant
although
higher
viral
genom
load
detect
nasal
secret
sever
case
vs
differ
statist
signific
figur
p
viral
genom
load
also
analyz
durat
lrti
time
sampl
illustr
figur
significantli
higher
viral
genom
load
found
infant
day
less
lower
respiratori
tract
symptom
compar
day
p
thu
higher
viral
load
detect
rsv
infect
infant
earlier
lrti
present
vs
final
analyz
stage
day
lrti
present
sever
infect
figur
found
viral
genom
load
day
less
lrti
compar
moder
sever
lrti
vs
p
howev
later
lrti
stage
day
infant
sever
rsv
lrti
significantli
higher
viral
genom
load
vs
p
independ
viral
factor
rsv
diseas
sever
explor
bivari
tabl
multivari
analys
rsv
antigen
group
genotyp
viral
genom
load
predict
sever
infect
higher
odd
ratio
although
statist
signific
detect
rsv
genom
load
analyz
respect
durat
sever
lrti
higher
viral
independ
viral
factor
rsv
diseas
sever
explor
bivari
tabl
multivari
analys
rsv
antigen
group
genotyp
viral
genom
load
predict
sever
infect
higher
odd
ratio
although
statist
signific
detect
rsv
genom
load
analyz
respect
durat
sever
lrti
higher
viral
genom
load
infant
longer
durat
sever
lrti
p
associ
chang
adjust
age
gender
rsv
type
data
shown
recent
promis
report
develop
drug
therapeut
rsv
publish
respons
critic
medic
need
care
infant
moder
sever
rsv
ill
parallel
molecular
virolog
enhanc
abil
dissect
viral
contribut
sever
diseas
howev
mani
question
remain
unclear
direct
role
rsv
airway
injuri
clinic
outcom
studi
present
evid
viral
factorsrsv
group
genotyp
viral
genom
loadthat
might
affect
cours
sever
diseas
circul
rsv
santiago
de
chile
report
et
al
describ
cocircul
rsva
rsvb
antigen
group
domin
altern
year
also
describ
epidem
appear
earlier
greater
intens
rsvb
domin
result
two
consecut
year
show
altern
antigen
pattern
rsva
domin
rsvb
moreov
report
institut
public
health
isp
chile
earlier
rsv
epidem
occur
virus
rsvb
group
major
circul
rsv
associ
antigen
group
b
sever
diseas
observ
studi
agreement
major
public
area
regard
rsv
genotyp
expect
accord
global
transmiss
dynam
describ
duvvuri
et
al
recent
describ
rsva
ontario
genotyp
detect
popul
sinc
replac
rsva
sampl
collect
rsvb
ba
genotyp
identifi
hospit
patient
associ
found
circul
genotyp
ba
sever
lower
respiratori
tract
diseas
contrast
recent
report
recent
describ
genotyp
show
higher
sever
score
influenza
viru
continu
surveil
may
need
detect
new
emerg
genotyp
assess
immedi
effect
suscept
popul
recent
describ
genet
variat
present
three
rsv
surfac
protein
includ
g
protein
also
fusion
f
protein
major
determin
host
immun
respons
main
target
antivir
therapi
vaccin
strategi
genom
variat
viral
genom
might
impact
pathogen
process
diseas
thu
need
explor
beyond
genotyp
classif
studi
relationship
coinfect
virus
sever
detect
compar
infant
sole
rsv
infect
moreov
trend
although
signific
less
sever
rsv
diseas
presenc
coinfect
viral
agent
p
find
may
explain
part
older
age
coinfect
group
vs
day
p
also
relev
patient
rsvhrv
infect
shown
infant
hrv
bronchiol
older
like
asthmalik
characterist
also
agreement
associ
detect
famili
histori
asthma
atopi
group
rsv
coinfect
recent
public
describ
associ
rsv
load
sever
score
durat
hospit
intens
care
unit
requir
moreov
analyz
consid
day
symptom
prior
sampl
collect
shown
viral
clearanc
import
factor
consid
sinc
signific
differ
detect
genom
load
predict
capac
sever
depend
date
sampl
studi
confirm
greater
number
rsv
genom
copi
found
sampl
occur
earli
lrti
significantli
lower
sampl
collect
later
day
onset
cough
symptom
chose
marker
lrti
agreement
studi
zhou
et
al
el
saleebi
et
al
found
higher
viral
load
infant
sever
lrti
day
lower
respiratori
tract
symptom
infant
sever
lrti
day
less
ill
suggest
differ
kinet
viral
clearanc
postul
delay
viral
clearanc
contribut
greater
airway
injuri
longer
durat
sever
lrti
although
main
limit
studi
lack
sequenti
sampl
patient
believ
data
report
complement
limit
inform
collect
author
propos
simpl
clinic
approach
cough
marker
character
popul
may
benefit
possibl
futur
therapeut
approach
data
present
relat
genotyp
viral
load
drive
explor
viral
evolut
viral
dynam
primari
rsv
infect
relat
sever
observ
analyt
crosssect
studi
perform
consecut
sampl
infant
year
age
present
first
communityacquir
rsv
lrti
enrol
obtain
parent
legal
guardian
written
inform
consent
hospit
hospit
roberto
del
santiago
de
chile
winter
outbreak
may
septemb
inclus
criteria
first
document
episod
acut
lrti
posit
direct
immunofluoresc
assay
rsv
perform
hrr
central
laboratori
admiss
enrol
studi
within
first
h
hospit
admiss
infant
possibl
bacteri
infect
prematur
week
gestat
age
immunodefici
document
chronic
lung
heart
diseas
exclud
singl
nasopharyng
aspir
npa
sampl
obtain
accord
standard
respiratori
care
sampl
refriger
transport
virolog
laboratori
day
collect
divid
aliquot
order
perform
viral
diagnost
confirm
genotyp
analysi
viral
genom
load
quantif
demograph
clinic
data
collect
structur
interview
parent
legal
guardian
enrol
date
onset
lower
respiratori
symptom
defin
day
cough
start
durat
lower
respiratori
diseas
time
sampl
also
regist
addit
discharg
hospit
data
medic
record
extract
use
determin
sever
ill
moder
sever
base
previous
publish
clinic
score
singleplex
duplex
real
time
pcr
assay
analys
perform
laboratori
lit
pap
use
primer
probe
previous
describ
real
time
revers
transcriptionpcr
qpcr
use
detect
rna
virus
includ
rsva
rsvb
human
rhinoviru
hrv
coronavirus
cov
parainfluenza
viru
piv
type
influenza
viru
type
b
human
metapneumoviru
hmpv
real
timepcr
perform
detect
dna
pathogen
includ
adenoviru
bocaviru
mycoplasma
pneumonia
bordetella
pertussi
viral
genom
load
rsv
posit
sampl
determin
laboratori
pap
qpcr
threshold
cycl
ct
valu
determin
therebi
provid
semiquantit
measur
viral
genom
load
previous
describ
amplif
second
hypervari
region
g
gene
perform
use
primer
condit
pcr
reaction
previous
describ
pcr
product
purifi
sent
sequenc
sanger
method
macrogen
inc
seoul
korea
chromatogram
trace
visual
bioedit
sequenc
align
editor
version
confirm
qualiti
score
contig
assembl
seqman
program
lasergen
program
suit
dnastar
inc
madison
wi
usa
use
obtain
g
gene
sequenc
strain
fragment
bp
locat
second
hypervari
region
g
gene
obtain
base
methodolog
describ
peret
et
al
phylogenet
analys
perform
r
softwar
r
develop
core
team
includ
sequenc
refer
sequenc
retriev
genbank
rsv
group
genotyp
categor
achiev
base
cluster
distribut
within
phylogenet
tree
demograph
clinic
characterist
describ
use
frequenc
case
categor
variabl
measur
central
tendenc
dispers
continu
variabl
comparison
group
perform
use
mannwhitney
rank
sum
kruskal
walli
test
appropri
pvalu
consid
statist
signific
spearman
correl
test
use
analyz
relationship
viral
type
sever
associ
clinic
sever
independ
variabl
assess
test
logist
regress
analysi
foncecyt
studi
n
approv
local
ethic
committe
north
metropolitan
health
servic
octob
faculti
medicin
universidad
de
chile
june
inform
consent
sign
parent
studi
particip
although
neither
rsv
antigen
group
genotyp
associ
clinic
sever
delay
viral
clearanc
might
associ
greater
airway
injuri
thu
diseas
sever
new
antivir
drug
therapi
hold
promis
shorten
clearanc
rsv
respiratori
tract
thu
might
mitig
sever
diseas
